Chen Nai: For 14 years, SRESAN PHARMACEUTICAL, a manufacturer of toxic cold dripping cough syrup, has been accused of 17 children’s deaths in the Noda Plades, and has been operated in a homeless building in Kancheepuram in Tamil Nadu, and even the drug is appropriate. It is manufactured as an appropriate facility for regulation and no facility.The TN drug authorities finally woke up and checked the manufacturing device with licenses since 2011 and sealed the premises.After receiving a letter from the MP’s drug administrator, the inspection was performed in all stages, from raw material sourcing to drug manufacturing, testing and packaging.On October 3, TN, the deputy director of Drugs Control S Gurubarathi, the state’s license and control authorities, instructed the pharmaceutical company to interrupt the manufacture, sales and distribution of the drug, and the laboratory inspection was 48.6% of Diethylene Glycol prepared in Diethylene Glycol After revealing the solution, it was ordered to stop the manufacture, sales and distribution of drugs.SRIPERUMBUDUR MANIMEGALAI announced the exhibition notice to the company on Tuesday afternoon. The company has been asked to provide a detailed description of the quality of the drug and the inconsistency of the labeling. The police team of MP arrived in Chennai on Tuesday evening and will visit the facility on Wednesday morning to conduct a detailed investigation.According to the release of TN Drugs Control, the inspection of the manufacturing facility began several hours after receiving the MP request on October 1, despite the October 2 and October 2 holidays. The entire survey, including inspection, sampling, syrup analysis and production, was completed within two days.Kancheepuram of Senior Drugin Kumar P NITHIN KUMAR and R SASIKUMAR’s Tiruvallur R SASIKUMAR inspected the building and the company purchased the non -drug grade of Propylene Glycol, a drug manufacturing commodity, but there was no invoice for purchasing. Four other syrups manufactured with propylene glycol are found to be safe.The drug inspector reported in the report that the drug’s drug was “unsanitary condition” (in the corridor, filled in an area without air handling, labeled, and placed, there was no pest control measures, no purified water generation systems or cleaning procedures.Many violations, including the risk of pollution, have been listed in page 20.The case of G Ranganathan, the owner of sesan pharma, was raised by MP GOVT, but TN Health Department did not take measures against drug inspector who could produce drugs under unusable conditions.“Why could the device work if you could list a lot of problems after a single test?” I asked the former drug manager M Bhaskaran.Pharmaceuticals and cosmetics rules order inspectors to inspect the manufacturing devices in the area more than once a year to ensure that the license conditions and regulations of the law and the rules are strictly observed.Ranganathan, a chemist, founded the company in the 90s. The State Pharmaceutical Management Bureau said there was no mooring. Bhaskaran says, “Because no one has tracked or inspected the premises.”He quoted two reasons why the mountain must constantly monitor. In the late 80’s, the Pharmaceutical Control Department booked Ranganathan to sell syrup used to treat anemia according to the ‘food supplement’ category. He did not have a valid drug license.Second, National Regulator, the Central Drugs Standard Control Organization, warned the country about the inappropriate use of propylene glycol. The main risk of syrup manufacturing is to use a contaminated propylene glycol in the presence of diethylene glycol or ethylene glycol, especially children’s long -term failures and deaths.Experts say they need to take action against senior drug inspector. If they had done their duties properly, the children of Chhindwara would probably not have lost their lives.